METOJECT
MEDEXUS INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is METOJECT discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that METOJECT 7.5MG has been permanently discontinued (last updated July 5, 2022). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
METHOTREXATE INJECTION USP
PFIZER CANADA ULC
METHOTREXATE INJECTION BP
ACCORD HEALTHCARE INC
METOJECT SUBCUTANEOUS
MEDEXUS PHARMACEUTICALS INC.
METHOTREXATE INJECTION, BP
PHARMASCIENCE INC
METHOFILL SELF-DOSE INJECTOR
ACCORD HEALTHCARE INC
PMS-METHOTREXATE INJECTION
PHARMASCIENCE INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02320029
Strength
7.5MG
Dosage Form
SOLUTION
Route
INTRAVENOUS INTRAMUSCULAR INTRA-ARTERIAL
Active Ingredient
METHOTREXATE
Tier
Unrated
Last Updated
2022-07-05
Reason for Shortage
Other (Please describe in comments)